Bumetanide Injection
Product Images NDC 51662-1449

5 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 51662-1449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

Boxed Warning (Boxed Warning)
Warning text panel for Bumetanide Injection, USP. It states that the drug is a potent diuretic which, if administered in excessive amounts, can cause significant diuresis with water and electrolyte depletion. The text advises careful medical supervision with dose adjustments tailored to individual patient needs, referencing the Dosage and Administration section for details.*
FDA Label Image
FDA Label Image

Serialized Vial Labeling (Serialized Vial Labeling)

Serialized Vial Labeling (Serialized Vial Labeling)
Brown glass vial of Bumetanide Injection USP, 0.25 mg/mL (1 mg/4 mL) single dose vial. The label states it is for intravenous or intramuscular use and contains benzyl alcohol. Distributed by HF Acquisition Co LLC, DBA HealthFirst. The vial has a white cap and a QR code on the attached label.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of bumetanide showing its molecular arrangement with labeled functional groups including carboxyl (COOH), sulfonamide (SO2NH2), and others attached to a benzene ring.*
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
Label for Bumetanide Injection, USP, 0.25 mg/mL (1 mg/4 mL) single-dose vial for intravenous or intramuscular use. The label notes the presence of benzyl alcohol as a preservative and buffer ingredients. Labeler is HF Acquisition Co LLC, DBA HealthFirst. Storage instructions and lot information are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.